Neurofilament light chain: A novel blood biomarker in patients with ataxia telangiectasia

Neurofilaments: The C-Reactive Protein of Neurology

(2020) Kate L. Lambertsen et al.   Brain Sciences

NfL as a biomarker for neurodegeneration and survival in Parkinson disease

(2020) David Bäckström et al.   NEUROLOGY

Serum NFL discriminates Parkinson disease from atypical parkinsonisms

(2019) Tainá M. Marques et al.   NEUROLOGY

Blood neurofilament light chain as a biomarker of MS disease activity and treatment response

(2019) Jens Kuhle et al.   NEUROLOGY

Neurofilament as a potential biomarker for spinal muscular atrophy

(2019) Basil T. Darras et al.   Annals of Clinical and Translational Neurology

Serum neurofilament light chain in pediatric MS and other acquired demyelinating syndromes

(2019) Yu Yi M. Wong et al.   NEUROLOGY

Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3

(2019) Quan-Fu Li et al.   Molecular Neurodegeneration

Neuro biomarker levels measured with high-sensitivity digital ELISA differ between serum and plasma

(2019) Grant C O'Connell et al.   Bioanalysis

Serum and CSF neurofilament light chain levels in patients with acquired peripheral neuropathies

(2018) Sara Mariotto et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis

(2018) Federico Verde et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease

(2018) Raquel Sánchez-Valle et al.   Alzheimers Research & Therapy

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis

(2017) Lauren M Byrne et al.   LANCET NEUROLOGY

Neurofilament subunits are integral components of synapses and modulate neurotransmission and behavior in vivo

(2015) A Yuan et al.   MOLECULAR PSYCHIATRY

Ataxia telangiectasia: more variation at clinical and cellular levels

(2014) A.M.R. Taylor et al.   CLINICAL GENETICS

Antibody deficiency in patients with ataxia telangiectasia is caused by disturbed B- and T-cell homeostasis and reduced immune repertoire diversity

(2013) Gertjan J. Driessen et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The ATM protein kinase: regulating the cellular response to genotoxic stress and more

(2013) Yosef Shiloh et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases

(2013) Johanna Gaiottino et al.   PLoS One

Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: A genotype-phenotype study

(2011) Mijke M. M. Verhagen et al.   HUMAN MUTATION

Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene

(2008) E. R. Staples et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY